Capital Advantage, Inc. Merck & Co., Inc. Transaction History

Capital Advantage, Inc.

$570 Million
Q2 2025

A detailed history of Capital Advantage, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Capital Advantage, Inc. holds 8,231 shares of MRK stock, worth $707,783. This represents 0.11% of its overall portfolio holdings.

Number of Shares

8,231

Previous 9,527 13.6%

Holding current value

$707,783

Previous $855,000 23.86%

% of portfolio

0.11%

Previous 0.16%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 11, 2025	SELL	$73.47 - $87.12 $95,217 - $112,907	-1,296 Reduced 13.6%	8,231 $651,000
Q4 2024 Feb 14, 2025	BUY	$96.31 - $114.76 $917,545 - $1.09 Million	9,527 New	9,527 $947,000
Q2 2023 Aug 07, 2023	SELL	$108.61 - $118.38 $349,506 - $380,946	-3,218 Reduced 22.62%	11,006 $1.27 Million
Q1 2023 May 04, 2023	SELL	$102.94 - $114.86 $13,279 - $14,816	-129 Reduced 0.9%	14,224 $1.51 Million
Q4 2022 Jan 23, 2023	BUY	$87.44 - $112.11 $8,306 - $10,650	95 Added 0.67%	14,353 $0
Q3 2022 Oct 31, 2022	BUY	$84.53 - $94.96 $126,625 - $142,250	1,498 Added 11.74%	14,258 $1.23 Million
Q2 2022 Jul 21, 2022	SELL	$83.49 - $94.64 $5,259 - $5,962	-63 Reduced 0.49%	12,760 $1.16 Million
Q1 2022 May 10, 2022	SELL	$73.51 - $82.4 $53,588 - $60,069	-729 Reduced 5.38%	12,823 $1.05 Million
Q4 2021 Jan 21, 2022	BUY	$72.28 - $90.54 $110,154 - $137,982	1,524 Added 12.67%	13,552 $1.11 Million
Q3 2021 Oct 07, 2021	SELL	$71.68 - $78.83 $118,988 - $130,857	-1,660 Reduced 12.13%	12,028 $903,000
Q2 2021 Aug 16, 2021	SELL	$70.31 - $77.77 $4,288 - $4,743	-61 Reduced 0.44%	13,688 $1.07 Million
Q1 2021 Apr 26, 2021	BUY	$68.86 - $81.11 $107,628 - $126,774	1,563 Added 12.83%	13,749 $1.06 Million
Q4 2020 Feb 17, 2021	BUY	$71.77 - $79.65 $13,923 - $15,452	194 Added 1.62%	12,186 $988,000
Q3 2020 Nov 12, 2020	SELL	$73.18 - $82.95 $10,245 - $11,613	-140 Reduced 1.15%	11,992 $960,000
Q1 2020 May 08, 2020	BUY	$63.36 - $87.82 $33,327 - $46,193	526 Added 4.53%	12,132 $1.01 Million
Q4 2019 Feb 14, 2020	SELL	$77.58 - $87.54 $21,412 - $24,161	-276 Reduced 2.32%	11,606 $998,000
Q3 2019 Nov 12, 2019	SELL	$76.08 - $82.93 $29,366 - $32,010	-386 Reduced 3.15%	11,882 $1 Million
Q1 2019 May 10, 2019	BUY	$69.58 - $79.36 $41,887 - $47,774	602 Added 5.16%	12,268 $1.02 Million
Q4 2018 Feb 07, 2019	BUY	$65.24 - $75.71 $16,114 - $18,700	247 Added 2.16%	11,666 $891,000
Q3 2018 Nov 01, 2018	SELL	$57.69 - $67.84 $19,499 - $22,929	-338 Reduced 2.87%	11,419 $810,000
Q2 2018 Aug 01, 2018	SELL	$50.83 - $59.72 $37,105 - $43,595	-730 Reduced 5.85%	11,757 $714,000
Q1 2018 May 02, 2018	SELL	$50.96 - $59.23 $15,084 - $17,532	-296 Reduced 2.32%	12,487 $680,000
Q4 2017 Feb 13, 2018	SELL	$51.62 - $61.64 $24,416 - $29,155	-473 Reduced 3.57%	12,783 $719,000
Q3 2017 Oct 30, 2017	BUY	$58.67 - $63.13 $220,012 - $236,737	3,750 Added 39.45%	13,256 $849,000
Q2 2017 Aug 08, 2017	BUY	N/A	9,506	9,506 $609,000

Others Institutions Holding MRK

# of Institutions

3,842

Shares Held

1.96B

Call Options Held

29.2M

Put Options Held

30M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $218B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advantage, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Capital Advantage, Inc. with notifications on news.

Account

Capital Advantage, Inc. Merck & Co., Inc. Transaction History